Imiquimod
SM Garland - Current opinion in infectious diseases, 2003 - journals.lww.com
Imiquimod : Current Opinion in Infectious Diseases Imiquimod : Current Opinion in Infectious
Diseases Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts …
Diseases Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts …
Imiquimod; an international update on therapeutic uses in dermatology
S Tyring, M Conant, M Marini… - International journal …, 2002 - Wiley Online Library
Imiquimod, the first member of a new class of immune response modifiers, is approved for
the treatment of external genital and perianal warts. The clinical effect of imiquimod stems …
the treatment of external genital and perianal warts. The clinical effect of imiquimod stems …
A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses
E Stockfleth, T Meyer, B Benninghoff… - Archives of …, 2002 - jamanetwork.com
Background Actinic keratoses (AKs) are precancerous epidermal lesions found most
frequently on areas of the skin exposed to the sun. Several case studies published recently …
frequently on areas of the skin exposed to the sun. Several case studies published recently …
Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations
DN Sauder, RB Skinner, TL Fox… - Sexually transmitted …, 2003 - journals.lww.com
Topical Imiquimod 5% Cream as an Effective Treatment for Ext... : Sexually Transmitted Diseases
Topical Imiquimod 5% Cream as an Effective Treatment for External Genital and Perianal Warts …
Topical Imiquimod 5% Cream as an Effective Treatment for External Genital and Perianal Warts …
Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream
MS Chapman, SK Spencer… - Archives of …, 2003 - jamanetwork.com
Lentigo maligna (LM) is an in situ melanoma that occurs on the face and other sun-exposed
areas. It may histologically extend beyond the clinical borders of the lesion; therefore …
areas. It may histologically extend beyond the clinical borders of the lesion; therefore …
The treatment of verrucae pedis using Falknor's needling method: a review of 46 cases
B Longhurst, I Bristow - Journal of Clinical Medicine, 2013 - mdpi.com
Human Papilloma Virus (HPV) related verrucae pedis persist, seemingly evading host
immune surveillance, yet sometimes disappear with inflammation. The absence, or …
immune surveillance, yet sometimes disappear with inflammation. The absence, or …
[PDF][PDF] New and emerging topical approaches for actinic keratoses
JQ Del Rosso - Cutis, 2003 - cdn.mdedge.com
Controlled studies have shown the efficacy of topical diclofenac 3% gel for the treatment of
AKs. 22, 23, 27 In a double-blind, vehicle-controlled study evaluating 195 adult patients …
AKs. 22, 23, 27 In a double-blind, vehicle-controlled study evaluating 195 adult patients …
Anal dysplasia
CA Messick… - Surgical Oncology Clinics, 2017 - surgonc.theclinics.com
Anal dysplasia is a cytopathology term describing specific squamous cell morphology and
represents a varying degree of benign changes. Often a source of confusion, the current …
represents a varying degree of benign changes. Often a source of confusion, the current …
Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod cream
MT Nordsiek, KS Balaji - US Patent 9,072,876, 2015 - Google Patents
2018-02-26 Assigned to THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
reassignment THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT SECURITY …
reassignment THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT SECURITY …
2× 2× 2 week treatment regimen for treating actinic keratosis with pharmaceutical compositions formulated with 2.5% imiquimod
MT Nordsiek, SF Levy, JH Lee, JH Kulp… - US Patent …, 2012 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
42316709&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
42316709&utm_source= google_patent&utm_medium= platform_link&utm_campaign …